Effect of DP-1904, a thromboxane A 2 synthase inhibitor, on passive Heymann nephritis in rats

By Nagao T.   Nagamatsu T.   Suzuki Y.  

European Journal of Pharmacology, Vol. 316, Iss. 1, 1996-11 ,pp. : 73-80

Elsevier

Access to resources Recommend Favorite

Effect of E3040, an inhibitor of 5-lipoxygenase and thromboxane synthase, on rat bowel damage induced by lipopolysaccharide

By Oketani K.   Inoue T.   Murakami M.  

European Journal of Pharmacology, Vol. 427, Iss. 2, 2001-09 ,pp. : 159-166

Elsevier

Access to resources Recommend Favorite

G 619, a dual thromboxane synthase inhibitor and thromboxane A 2 receptor antagonist, inhibits tumor necrosis factor- biosynthesis

By Altavilla D.   Squadrito F.   Canale P.   Ioculano M.   Squadrito G.   Campo G.M.   Serrano M.   Sardella A.   Urna G.   Spignoli G.   Caputi A.P.  

European Journal of Pharmacology, Vol. 286, Iss. 1, 1995-11 ,pp. : 31-39

Elsevier

Access to resources Recommend Favorite

Thromboxane A 2 synthase inhibitor enhanced antithrombotic efficacy of GPIIb-IIIa receptor antagonist without increasing bleeding

By Kawano K.-i.   Hokamura K.   Kondo K.   Ikeda Y.   Suzuki Y.   Umemura K.  

European Journal of Pharmacology, Vol. 417, Iss. 3, 2001-04 ,pp. : 217-222

Elsevier

Access to resources Recommend Favorite

Urinary nitrate excretion in cholesterol-fed rabbits: effect of a chronic treatment by N-iminoethyl-l-lysine, a selective inhibitor of inducible nitric oxide synthase

By Behr-Roussel D.   Rupin A.   Simonet S.   Fabiani J.-N.   Verbeuren T.J.  

European Journal of Pharmacology, Vol. 388, Iss. 3, 2000-02 ,pp. : 275-279

Elsevier

Access to resources Recommend Favorite